Back to search
FDAFDA · Food and drugs·Recall number D-0629-2024

Methotrexate Tablets, USP, 2.5mg, 100-count Bottle, RX Only, Distributed By: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC# 69238-1423-1

Published August 14, 2024 · Recall initiated: August 1, 2024

Summary

FDA records drug Class III recall D-0629-2024, published August 14, 2024 and initiated August 1, 2024. Recalling firm: Amneal Pharmaceuticals, LLC; Status: Completed; Reported quantity: 12,624 bottles; Lot: Lot # BB29124, Exp. 02/28/2026. Class III means the product is not likely to cause adverse health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Tablets: Potential presence of Fludrocortisone Acetate Tablet USP 0.1 mg within the Methotrexate 2.5 mg 100-count Bottle.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Amneal Pharmaceuticals, LLC
Distributor
Nationwide in the USA
Lot
Lot # BB29124, Exp. 02/28/2026
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Methotrexate Tablets, USP, 2.5mg, 100-count Bottle, RX Only, Distributed By: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC# 69238-1423-1 recalled?

Yes. FDA published recall D-0629-2024 on August 14, 2024. Reported hazard: Presence of Foreign Tablets: Potential presence of Fludrocortisone Acetate Tablet USP 0.1 mg within the Methotrexate 2.5 mg 100-count Bottle.

What should I do if I have this product?

Voluntary: Firm initiated · Letter